Comparison of <i>BRAF</i> Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients

Comparison of <i>BRAF</i> Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients

Malignant melanoma (MM) is one of the deadliest skin cancers. <i>BRAF</i> mutation status plays a predominant role in the management of MM patients. The aim of this study was to compare <i>BRAF</i> mutational testing performed by conventional nucleotide sequencing approaches...

Full description

Bibliographic Details
Main Authors: Maria Colombino, Carla Rozzo, Panagiotis Paliogiannis, Milena Casula, Antonella Manca, Valentina Doneddu, Maria Antonietta Fedeli, Maria Cristina Sini, Grazia Palomba, Marina Pisano, Paolo A. Ascierto, Corrado Caracò, Amelia Lissia, Antonio Cossu, Giuseppe Palmieri
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Journal of Clinical Medicine
Subjects:
melanoma
targeted therapies
BRAF
druggable mutations
real-time PCR
NGS assay
Online Access:https://www.mdpi.com/2077-0383/9/8/2430

Internet

https://www.mdpi.com/2077-0383/9/8/2430

Similar Items